89bio, Inc. (ETNB)
NASDAQ: ETNB · Real-Time Price · USD
7.98
+0.04 (0.50%)
Dec 26, 2024, 1:08 PM EST - Market open
89bio Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for 89bio stock have an average target of 30.33, with a low estimate of 12 and a high estimate of 49. The average target predicts an increase of 280.08% from the current stock price of 7.98.
Analyst Consensus: Buy
* Price targets were last updated on Nov 11, 2024.
Analyst Ratings
The average analyst rating for 89bio stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 3 | 3 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $29 | Strong Buy | Reiterates | $29 | +263.41% | Nov 11, 2024 |
| Raymond James | Raymond James | Strong Buy Maintains $53 → $49 | Strong Buy | Maintains | $53 → $49 | +514.04% | Nov 8, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $29 | Buy | Reiterates | $29 | +263.41% | Sep 20, 2024 |
| Raymond James | Raymond James | Strong Buy Maintains $50 → $53 | Strong Buy | Maintains | $50 → $53 | +564.16% | Aug 6, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $13 → $12 | Hold | Maintains | $13 → $12 | +50.38% | Aug 6, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.30
from -2.00
EPS Next Year
-3.02
from -3.30
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | 50.2M | |||
| Avg | n/a | n/a | 25.3M | |||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -3.13 | -2.56 | -0.82 | |||
| Avg | -3.30 | -3.02 | -2.57 | |||
| Low | -3.43 | -3.69 | -3.32 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.